Search Within

Teja Muralidhar Kalidindi

Formats
  1. Journal Article (23)
  2. Meeting Abstract (16)
Groups
  1. Radiology, Department of (38)
  2. Radiochemistry and Imaging Sciences Service (37)
  3. Sloan Kettering Institute Postdocs (34)
  4. GSK Faculty (26)
  5. Sloan Kettering Institute Faculty (19)
  6. Molecular Pharmacology and Chemistry Program Faculty (18)

More Groups

People
  1. Nagavarakishore Pillarsetty (31)
  2. Steven Larson (14)
  3. Jason Lewis (12)
  4. Sang Gyu Lee (11)
  5. Blesida Punzalan (8)
  6. Darren Veach (7)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (8)
  4. 2022 (4)
  5. 2021 (8)
  6. 2020 (5)

More Years

Publications
  1. Journal of Nuclear Medicine (14)
  2. European Journal of Nuclear Medicine and Molecular Imaging (3)
  3. Clinical Cancer Research (2)
  4. Nature Communications (2)
  5. Nuclear Medicine and Biology (2)
  6. ACS Pharmacology & Translational Science (1)

More Publications

Publishers
  1. Society of Nuclear Medicine (14)
  2. American Association for Cancer Research (4)
  3. Springer (4)
  4. Cell Press (2)
  5. Elsevier Science Inc. (2)
  6. Elsevier Science, Inc. (2)

More Publishers

Results (39)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Chemical tools for epichaperome-mediated interactome dysfunctions of the central nervous system
    Journal Article

    Bolaender, A.; Zatorska, D.; He, H.; Joshi, S.; Sharma, S.; Digwal, C. S.; Patel, H. J.; Sun, W.; Imber, B. S.; Ochiana, S. O.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • Significance of targeting the antiapoptotic pathway in castration-sensitive prostate cancer
    Meeting Abstract

    Chakraborty, G.; Hirani, R.; Nandakumar, S.; Kalidindi, T. M.; Fidele, D.; Rajanala, S. H.; Mazzu, Y. Z.; Yoshikawa, Y.; Jehane, L. E.; Lee, G. S. M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • PSA-targeted alpha-, beta-, and positron-emitting immunotheranostics in murine prostate cancer models and nonhuman primates
    Journal Article

    Veach, D. R.; Storey, C. M.; Lückerath, K.; Braun, K.; von Bodman, C.; Lamminmäki, U.; Kalidindi, T.; Strand, S. E.; Strand, J.; Altai, M.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • γ-tocotrienol-loaded liposomes for radioprotection from hematopoietic side effects caused by radiotherapeutic drugs
    Journal Article

    Lee, S. G.; Kalidindi, T. M.; Lou, H.; Gangangari, K.; Punzalan, B.; Bitton, A.; Lee, C. J.; Vargas, H. A.; Park, S.; Bodei, L.; more...
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • Predicting gemcitabine delivery by (18)F-FAC PET in murine models of pancreatic cancer
    Journal Article

    Russell, J.; Grkovski, M.; O'Donoghue, I. J.; Kalidindi, T. M.; Pillarsetty, N.; Burnazi, E. M.; Kulick, A.; Bahr, A.; Chang, Q.; LeKaye, H. C.; more...
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • Novel radioiodinated theranostic agent targeting PSMA for prostate cancer
    Meeting Abstract

    Kalidindi, T. M.; Lee, S. G.; Lewis, J.; Larson, S.; Pillarsetty, N.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Effect of reducing specific activity of [(177)Lu]-DKFZ-PSMA617 on uptake in the tumor, salivary gland and kidney
    Meeting Abstract

    Kalidindi, T. M.; Lee, S. G.; Punzalan, B.; Veach, D.; Jou, K.; Chakraborty, G.; Tagawa, S.; Bander, N.; Lewis, J.; Larson, S.; more...
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Delta-like ligand 3 (DLL3) is a novel target for molecular imaging of neuroendocrine prostate cancer
    Meeting Abstract

    Korsen, J.; Kalidindi, T.; Khitrov, S.; Khuram, H.; Piorier, J.; Rudin, C.; Chen, Y.; Pillarsetty, N. V. K.; Lewis, J.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • GT3-Nano based radioprotector drug promotes rapid recovery from (153)Sm-EDTMP induced myelotoxcity
    Meeting Abstract

    Lee, S. G.; Kalidindi, T. M.; Punzalan, B.; Pillarsetty, N.; Larson, S.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save
  • Genetic signature of prostate cancer mouse models resistant to optimized hK2 targeted α-particle therapy
    Journal Article

    Bicak, M.; Lückerath, K.; Kalidindi, T.; Phelps, M. E.; Strand, S. E.; Morris, M. J.; Radu, C. G.; Damoiseaux, R.; Peltola, M. T.; Peekhaus, N.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2020)

    Fulltext@MSK | Save